Biography

Warren Kaplan, PhD, JD, MPH, MS, has over 30 years’ experience as a field biologist/analytical chemist, an intellectual property attorney, a pharmaceutical policy analyst, and a project leader. Currently, Dr. Kaplan is Assistant Professor of International Health at Boston University School of Public Health, where he teaches courses in pharmaceutical policy, intellectual property policy, and access to medicines and antimicrobial resistance. From 1977 to 1989, Dr. Kaplan worked at Harvard University, traveling to the Caribbean, Ecuador, and Brazil to study global budgets of greenhouse gases, including methane and nitrous oxide. He was part of the first group to measure the global distribution and production of these important climate modifiers. He was Assistant General Counsel at Biogen, where he managed a multimillion portfolio of intellectual property related to small molecules and biologics. He consults extensively with the World Health Organization, UNITAID, UNICEF (South Africa, Mozambique), the World Bank, and the Clinton Foundation (Rwanda, Kenya) on a variety of projects involving access to medicines. Dr. Kaplan has worked and lived in Geneva as Technical Officer on the “Priority Medicines for Europe and the World” Project. He is involved in a similar project on medical devices. Dr. Kaplan’s current research interests focus on pharmaceutical policies relating to generic medicines and biologics as well as use of social networking and mobile phones as health care interventions. He holds a PhD in Biology from Boston University, a JD from Suffolk University (cum laude), an MPH in International Health from Boston University, and an MS from Texas A&M University .

Dr. Kaplan is also a member of the World Health Organization Collaborating Center on Pharmaceutical Policy (WHOCCPP) which provides research and programs for the improvement of access to essential drugs in developing countries and the development of policies that promote greater affordability and the appropriate usage of these medicines.

Projects

• Priority Medicines for Europe and the World

Publications